David C. Currow

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 6.2K citations · Full text

Medicine, Biostatistics, Oncology +17

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

Melina Arnold, Mark J. Rutherford, Aude Bardot et al. · The Lancet Oncology · 2019 · 1.1K citations · Full text

Medicine, Health Sciences, Oncology +17

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

Jennifer S. Temel, Amy P. Abernethy, David C. Currow et al. · The Lancet Oncology · 2016 · 628 citations

Medicine, Oncology, Pharmacology +12

The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]

Amy P. Abernethy, Tania Shelby‐James, Belinda Fazekas et al. · BMC Palliative Care · 2005 · 529 citations · Full text

Medicine, Oncology, Outcomes Research +9

Health-related quality of life measured using the EQ-5D–5L: South Australian population norms

Nikki McCaffrey, Billingsley Kaambwa, David C. Currow et al. · Health and Quality of Life Outcomes · 2016 · 501 citations · Full text

Pharmacy, Community Health, Health Assessment +16